On Thursday, BMO Capital Markets adjusted its outlook on Corpay (NYSE:CPAY) shares, reducing the price target to $440 from the previous $450, while retaining an Outperform rating on the stock. The company, currently trading at $388.67 with a market capitalization of $27.09 billion, has shown remarkable momentum with a 43.44% gain over the past six months according to InvestingPro data. The adjustment follows Corpay’s recent guidance influenced by macroeconomic factors, specifically foreign exchange depreciation, which has had an impact on the company’s projections for 2025.
Rufus Hone, an analyst with BMO Capital, acknowledged the positive underlying trends for Corpay, such as the acceleration in fourth-quarter organic growth and the raised guidance for organic growth in 2025. Additionally, Hone noted that the earnings per share (EPS) guidance excluding macro factors aligns with previous forecasts. InvestingPro analysis reveals the company maintains a GREAT financial health score of 3.04, though it trades at a relatively high P/E ratio of 27.07. Despite these encouraging signs, the macroeconomic headwinds have led to a tempered outlook for the company’s 2025 guidance.
The analyst expressed a belief that the market had expected a more modest macro headwind, especially concerning EPS. As a result, Hone anticipates that Corpay’s stock may retract some of its year-to-date gains. Nonetheless, he foresees potential modest upside for Corpay’s 2025 guidance, suggesting that faster-than-expected organic growth and strategic capital allocation could positively influence the company’s financials. Notably, the current guidance does not factor in potential mergers and acquisitions or stock buybacks.
Investors are expected to monitor Corpay’s performance closely, considering the revised price target and the analyst’s outlook on the company’s growth prospects and response to macroeconomic challenges. The market’s reaction to Corpay’s adjusted guidance and BMO Capital’s updated price target will be a point of interest in the trading sessions ahead. With analyst targets ranging from $330 to $450 and six analysts recently revising earnings downward, subscribers to InvestingPro can access additional insights through the comprehensive Pro Research Report, which provides detailed analysis of Corpay’s valuation and growth prospects among 1,400+ top stocks.
In other recent news, Corpay reported fourth-quarter earnings that exceeded expectations, but the company’s revenue fell short of estimates. The corporate payments firm posted adjusted earnings per share of $5.36, surpassing the analyst consensus of $5.32. However, the revenue of $1.03 billion missed the anticipated $1.06 billion. For the full year 2025, Corpay projected an adjusted EPS of $20.75 to $21.25, which is below the expected $21.93. The company’s revenue forecast for 2025 is between $4.35 billion and $4.45 billion, also falling short of the $4.45 billion consensus estimate.
In other developments, Keefe, Bruyette & Woods adjusted their financial outlook for Corpay, raising the price target to $445 from the previous $415 while maintaining an Outperform rating. This revision followed Corpay’s recent earnings release, which led to a modification of the firm’s earnings per share estimates for the years 2025 and 2026. Analysts at Keefe, Bruyette & Woods now expect EPS of $21.07 and $24.21 for 2025 and 2026, respectively, a decrease from their previous estimates of $21.50 and $25.66.
Keefe, Bruyette & Woods also highlighted Corpay’s management’s positive stance on the company’s future, particularly regarding the potential for growth through mergers and acquisitions, and capital management strategies. Despite a potential for modest organic growth weakness in the company’s consolidated outlook for 2025, the firm believes that Corpay’s overall prospects remain favorable.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.